Investor Type | Firm |
Type of Fund | Private Equity Fund |
Industries | BioTech • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Pharmaceutical (& Medicine) |
Stages | Seed Round, Series A, Series B |
Investing | United States |
Investment Range | $100,000 - $5,000,000 |
Investment Sweet Spot | $1,500,000 |
Bain Capital Life Sciences is a leading investment fund operating as part of the broader Bain Capital, a global private investment firm headquartered at 200 Clarendon Street, Boston, Massachusetts. Focused within the realms of BioTech, HealthTech, Medical Devices, Healthcare, Wellness, and Pharmaceutical industries, Bain Capital Life Sciences specializes in private equity investments. They adeptly employ their expertise in equity to fuel growth and innovation in these sectors. With an investment spectrum ranging from a minimum of $100,000 to a maximum of $5,000,000, they target a sweet spot investment of around $1,500,000. Bain Capital Life Sciences is strategically positioned to engage with companies at various stages, namely Seed Round, Series A, and Series B, leveraging deep sector expertise and capabilities to transform businesses. They aim to create value by partnering with visionary leaders, accelerating growth from seed-to-scale, and structuring bespoke solutions tailored to the unique demands of the life sciences sector. Their investment philosophy is heavily influenced by cross-platform collaboration which connects vertical and regional expertise to deliver unconventional insights and drive transformative ideas. Bain Capital Life Sciences is part of Bain Capital's integrated platform which also includes Growth & Venture Capital, Solutions Credit & Capital Markets, and Real Assets, among others. Additionally, they place a strong emphasis on ESG (Environmental, Social, and Governance) integration across their portfolios, aiming to achieve sustainable growth and positive, long-term impacts on both society and the environment.